Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 10
2003 8
2004 9
2005 7
2006 10
2007 9
2008 15
2009 15
2010 11
2011 16
2012 17
2013 11
2014 12
2015 20
2016 13
2017 15
2018 14
2019 16
2020 18
2021 34
2022 35
2023 42
2024 23

Text availability

Article attribute

Article type

Publication date

Search Results

332 results

Results by year

Filters applied: . Clear all
Page 1
Research Advances on Matrine.
Sun XY, Jia LY, Rong Z, Zhou X, Cao LQ, Li AH, Guo M, Jin J, Wang YD, Huang L, Li YH, He ZJ, Li L, Ma RK, Lv YF, Shao KK, Zhang J, Cao HL. Sun XY, et al. Among authors: rong z. Front Chem. 2022 Apr 1;10:867318. doi: 10.3389/fchem.2022.867318. eCollection 2022. Front Chem. 2022. PMID: 35433636 Free PMC article. Review.
Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T cells for T cell malignancies.
Watanabe N, Mo F, Zheng R, Ma R, Bray VC, van Leeuwen DG, Sritabal-Ramirez J, Hu H, Wang S, Mehta B, Srinivasan M, Scherer LD, Zhang H, Thakkar SG, Hill LC, Heslop HE, Cheng C, Brenner MK, Mamonkin M. Watanabe N, et al. Among authors: zheng r. Mol Ther. 2023 Jan 4;31(1):24-34. doi: 10.1016/j.ymthe.2022.09.003. Epub 2022 Sep 9. Mol Ther. 2023. PMID: 36086817 Free PMC article.
Particle radiotherapy in the era of radioimmunotherapy.
Zhou Z, Guan B, Xia H, Zheng R, Xu B. Zhou Z, et al. Among authors: zheng r. Cancer Lett. 2023 Jul 28;567:216268. doi: 10.1016/j.canlet.2023.216268. Epub 2023 Jun 17. Cancer Lett. 2023. PMID: 37331583 Review.
Research Advances on Anti-Cancer Natural Products.
Guo M, Jin J, Zhao D, Rong Z, Cao LQ, Li AH, Sun XY, Jia LY, Wang YD, Huang L, Li YH, He ZJ, Li L, Ma RK, Lv YF, Shao KK, Cao HL. Guo M, et al. Among authors: rong z. Front Oncol. 2022 May 6;12:866154. doi: 10.3389/fonc.2022.866154. eCollection 2022. Front Oncol. 2022. PMID: 35646647 Free PMC article. Review.
The role of PET/CT in radiotherapy for nasopharyngeal carcinoma.
Li H, Kong Z, Xiang Y, Zheng R, Liu S. Li H, et al. Among authors: zheng r. Front Oncol. 2022 Oct 21;12:1017758. doi: 10.3389/fonc.2022.1017758. eCollection 2022. Front Oncol. 2022. PMID: 36338692 Free PMC article. Review.
Integrating Categorization and Decision-Making.
Zheng R, Busemeyer JR, Nosofsky RM. Zheng R, et al. Cogn Sci. 2023 Jan;47(1):e13235. doi: 10.1111/cogs.13235. Cogn Sci. 2023. PMID: 36655984 Free PMC article.
UBR5 Acts as an Antiviral Host Factor against MERS-CoV via Promoting Ubiquitination and Degradation of ORF4b.
Zhou Y, Zheng R, Liu D, Liu S, Disoma C, Li S, Liao Y, Chen Z, Du A, Dong Z, Zhang Y, Liu P, Razzaq A, Chen D, Chen X, Zhong X, Liu S, Tao S, Liu Y, Xu L, Deng X, Li J, Jiang T, Zhao J, Li S, Xia Z. Zhou Y, et al. Among authors: zheng r. J Virol. 2022 Sep 14;96(17):e0074122. doi: 10.1128/jvi.00741-22. Epub 2022 Aug 18. J Virol. 2022. PMID: 35980206 Free PMC article.
332 results